Remission of HIV Myelopathy After Highly Active Antiretroviral Therapy
Neurol 54:267-268, Staudinger,R.&Henry,K., 2000
Estrogen for Alzheimer's Disease in Women, Randomized, Double-Blind, Placebo-Controlled Trial
Neurol 54:295-301, Henderson,V.W.,et al, 2000
Endovascular Treatment of Ruptured Posterior Circulation Cerebral Aneurysms, Clinical and Angiographic Outcomes
Stroke 31:100-110, Lempert,T.E.,et al, 2000
Neurogene Therapy for the 21st Century
Arch Neurol 57:54, Brady,R.O., 2000
Eletriptan in Acute Migraine:A Double-Blind,Placebo-Controlled Comparison to Sumatriptan
Neurol 54:156-163, Goadsby,P.J.,et al, 2000
Nitrous Oxide Anesthesia-Associated Myelopathy
ArchNeurol 57:380-382, Marie,R.,et al, 2000
Bipolar Permanent Magnets for the Treatment of Chronic Low Back Pain
JAMA 283:1322-1325, Collacott,E.A.,et al, 2000
Vagus Nerve Stimulation Therapy for Epilepsy in Older Adults
Neurol 54:1179-1182, Sirven,J.I.,et al, 2000
Cerebral Sinus Thrombosis Diagnosed by MRI and MR Venography in Cancer Patients
Neurol 54:1222-1226, Raizer,J.J.&DeAngelis,L.M., 2000
Decision Analysis and Guidelines for Anticoagulant Therapy to Prevent Stroke in Patients with Atrial Fibrillation
Lancet 355:956-962, Thomson,R.,et al, 2000
Treatment of Acute Disseminated Encephaloymelitis with Intravenous Immunoglobulin
Neurol 54:1370-1372, Sahlas,D.J.,et al, 2000
Glossopharyngeal Neuralgia and MS
Neurol 54:1368-1370, Minagar,S.&Sheremata,W.A., 2000
Shaky-Leg Syndrome and Vitamin B12 Deficiency
NEJM 342:981, Benito-Leon,J.&Porta-Etessam,J., 2000
Tourette's Syndrome Improvement with Pergolide in a Randomized, Double-Blind, Crossover Trial
Neurol 54:1310-1315, Gilbert,D.L.,et al, 2000
Blindness in a Strict Vegan
NEJM 342:897-898, Milea,D.,et al, 2000
Verapamil in the Prophylaxis of Episodic Cluster Headache:A Double-Blind Study Versus Placebo
Neurol 54:1382-1385, Leone,M.,et al, 2000
Triptans and Migraine
Lancet 355:860-861, Bateman,D.N., 2000
Botulinum Toxin A as Treatment for Drooling Saliva in PD
Neurol 54:244-247, Pal,P.K.,et al, 2000
A Randomized Trial of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Neurol 54:603-607, Sanders,D.B.,et al, 2000
Objective Changes in Motor Function During Placebo Treatment in PD
Neurol 54:710-714, Goetz,C.G.,et al, 2000
Effects of Bilateral Posteroventral Pallidotomy on Gait of Subjects with Parkinson Disease
Arch Neurol 57:198-204, Siegel,K.L.&Metman,L.V., 2000
Tolcapone and Hepatotoxic Effects
Arch Neurol 57:263-267, Olanow,C.W.&Tasmar Advisory Panel, 2000
Outcome of Surgery for Thoracic Outlet Syndrome in Washington State Workers' Compensation
Neurol 54:1252-1257, Franklin,G.M.,et al, 2000
Ulnar Neuropathy at the Elbow
Muscle & Nerve 23:450-452, Campbell,W.W., 2000
Prolongation of Midazolam Half-Life After Sustained Infusion for Status Epilepticus
Neurol 54:1366-1368, Naritoku,D.K.&Sinha,S., 2000
Vocal Cord Adduction During Vagus Nerve Stimulation for Treatment of Epilepsy
Neurol 54:1388-1389, Zumsteg,D.,et al, 2000
Retrospective Case Note Review of Acute and Inpatient Stroke Outcomes
BMJ 320:1511-1512, Aly,N.,et al, 2000
Intravenous Valproate in Pediatric Epilepsy Patients with Refractory Status Epilepticus
Neurol 54:2188-2189, Uberall,M.A.,et al, 2000
Reduced Prevalence of AD in Users of NSAIDs and H2 Receptor Antagonists
Neurol 54:2066-2071, Anthony,J.C.,et al, 2000
Practice Paramenter: The Role of Corticosteroids in the Management of Acute Monosymptomatic Optic Neuritis
Neurol 54:2039-2044, Kaufman,D.I.,et al, 2000
Remedies for HIV-Associated Peripheral Neuropathy
Neurol 54:2037-2038, Berger,J.R.&Nath,A., 2000
Indications for Early Aspirin Use in Acute Ischemic Stroke
Stroke 31:1240-1249, Chen,Z.,et al, 2000
Long-Term Follow-Up of Unilateral Pallidotomy in Advanced Parkinson's Disease
NEJM 342:1708-1714, Fine,J.,et al, 2000
Systematic Comparison of the Early Outcome of Angioplasty and Endarterectomy for Symptomatic Carotid Artery Disease
Stroke 31:1439-1443, Golledge,J.,et al, 2000
Dopamine Agonists: Their Role in the Treatment of Parkinson's Disease
JNNP 68;685-690, Brooks,D.J., 2000
Endovascular Treatment of Dural Sinus Thrombosis With Rheolytic Thrombectomy and Intra-Arterial Thrombolysis
Stroke 31:1420-1425, Chow,K.,et al, 2000
Status Epilepticus Associated with Cefepime
Neurol 54:2153-2155, Dixit,S.,et al, 2000
Working Off Low Back Pain
Lancet 355:1929-1930, Biering-Sorensen,F.&Bendix,A.F., 2000
New Drugs:Which Should Be Included in the Formulary?, Epilepsy:All New Drugs Should Be Included
Arch Neurol 57:272-273,275, Pierre-Louis,S.J.C., 2000
Restrictions on the Availability of Antiepileptic Drugs
Arch Neurol 57:273-274,275, Bergen,D.C., 2000
Early Identification of Refracvtory Epilepsy
NEJM 342:314-319, Kwan,P.&Brodie,M.J., 2000
Role of Brain Biopsy in the Management of Focal Brain Lesions in HIV-Infected Patients
Neurol 54:993-997, Antinori,A.,et al, 2000
Treatment of Atherosclerotic Disease at the Cervical Carotid Bifurcation: Current Status and Review of the Literature
AJNR 21:444-450, Connors III,J.J.,et al, 2000
Aspirin for the Primary Prevention of Stroke and Other Major Vascular Events
ArchNeurol 57:326-332,306, Hart,R.G.,et al, 2000
Arterial Dissections Complicating Cerebral Angiography and Cerebrovascular Interventions
AJNR 21:541-545, Cloft,H.J.,et al, 2000
Diagnosis and Treatment of Intravascular Lymphomatosis
ArchNeurol 57:374-377, Baumann,T.P.,et al, 2000
Neurological Emergencies: Acute Stroke
JNNP 68:277-288, Davenport,R. & Dennis,M., 2000
Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
JAMA 283:1145-1150,1189, Albers,G.W.,et al, 2000
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
JAMA 283:1151-1158,1189, Katzan,I.L.,et al, 2000
Short-Term Arteriographic and Clinical Outcome After Cerebral Angioplasty and Stenting for Intracranial Vertebrobasilar and Carotid ATherosclerotic Occlusive Disease
AJNR 21:249-254, Mori,T.,et al, 2000